Kebede Sintayehu, Afework Mekbeb, Debella Asfaw, Ergete Wondwossen, Makonnen Eyasu
Department of Anatomy, Faculty of Medicine, Addis Ababa University, P.O. Box 18309, Addis Ababa, Ethiopia.
Department of Anatomy,Medical Faculty, Addis Ababa University, Addis Ababa, Ethiopia.
BMC Res Notes. 2016 Jan 27;9:49. doi: 10.1186/s13104-016-1861-5.
The butanol fractionated root extract of Asparagus africanus Lam., a traditional herb widely used to treat various ailments were analyzed for the presence of potential toxicity after single (acute) and repeated (subchronic) dose oral administration in adult swiss albino mice using gavages.
For the acute study, butanol fractionated extract of the plant was administered in single doses of 1000, 3000 and 5000 mg/kg body weight. In the sub-chronic dose study, the extract was administered at doses of 300 and 600 mg/kg body weight/day for 42 days. Selected hematological and biochemical parameters of the blood followed by histopathological analysis were investigated after 42 days of daily administrations. The results were expressed as M ± SE, and differences at P < 0.05 was considered significant. One way analysis of variance (ANOVA) and least significant difference tests were employed to check the significant differences between the various parameters of the experimental groups.
In the acute study, the extract did not caused dose-dependent general behavioral adverse effects, body weight change and mortality. The single dose toxicity studies therefore showed that the butanol fraction of the extract has high safety profile when given orally. After 42 days of daily dosing, in the sub-chronic study, no clinically significant changes were observed for hematological and biochemical parameters. Except an occasional small number of focal mononuclear lymphocytic cells infiltrations around the central and portal triad of the liver of a few mice, the histopathological parameters do not show significant change.
It is concluded that, the butanol fractionated extract from A. africanus at the given dose does not show significant toxicity. The presence of focal inflammation on the liver of a few mice may be associated to the presence of flavonoid glycoside in the butanol fractionated extract.
非洲天门冬是一种广泛用于治疗各种疾病的传统草药,采用灌胃法对成年瑞士白化小鼠单次(急性)和重复(亚慢性)口服给药后,分析其丁醇分级根提取物中潜在毒性的存在情况。
在急性研究中,以1000、3000和5000mg/kg体重的单剂量给予该植物的丁醇分级提取物。在亚慢性剂量研究中,以300和600mg/kg体重/天的剂量给予提取物,持续42天。在每日给药42天后,对选定的血液学和生化参数进行研究,随后进行组织病理学分析。结果以M±SE表示,P<0.05的差异被认为具有显著性。采用单因素方差分析(ANOVA)和最小显著差异检验来检查实验组各参数之间的显著差异。
在急性研究中,提取物未引起剂量依赖性的一般行为不良反应、体重变化和死亡率。因此,单次剂量毒性研究表明,该提取物的丁醇部分口服时具有较高的安全性。在亚慢性研究中,每日给药42天后,血液学和生化参数未观察到临床显著变化。除少数小鼠肝脏中央和门脉三联体周围偶尔有少量局灶性单核淋巴细胞浸润外,组织病理学参数未显示出显著变化。
得出结论,给定剂量的非洲天门冬丁醇分级提取物未显示出显著毒性。少数小鼠肝脏出现局灶性炎症可能与丁醇分级提取物中黄酮糖苷的存在有关。